Cargando…

Increasing COVID-19 Vaccination Rates Amongst Children with Sickle Cell Disease: A Quality Improvement Project

Detalles Bibliográficos
Autores principales:	Yan, Adam P, Archer, Natasha M., Arnold, Dianne, Hansbury, Eileen, Heeney, Matthew M., Johnson, Dave, Lichtman, Erika, McMullan, Heather, Morrissey, Lisa, Ilowite, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Oral Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665195/ http://dx.doi.org/10.1182/blood-2022-158215

Ejemplares similares

S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
por: Heeney, M, et al.
Publicado: (2022)

O-13: INHIBITION OF THE ENDOCANNABINOID REGULATING ENZYME MONOACYLGLYCEROL LIPASE AMELIORATES THE HYPER-NOCICEPTIVE PHENOTYPE IN THE BERKELEY MOUSE MODEL OF SICKLE CELL DISEASE
por: K., GOLDSBOROUGH, et al.
Publicado: (2022)

The use of ASET (Anti Staph Epidermidis Titre) in the diagnosis of ventriculo-atrial shunt infection
por: Reaper, Jacqueline, et al.
Publicado: (2010)

O002 A novel, optogenetics based therapy for obstructive sleep apnea
por: Knapman, F, et al.
Publicado: (2022)

S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS STUDY
por: Heeney1, Matthew, et al.
Publicado: (2023)

Sharing the love: networking amongst cytometrists
por: Davies, Derek
Publicado: (2015)

O-02: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
por: R., BIONDI, et al.
Publicado: (2022)

O-08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON-SICKLE SIBLINGS
por: P., BANGIRANA, et al.
Publicado: (2022)

Using qualitative research to understand what outcomes matter to patients: direct and indirect approaches to outcome elicitation
por: Mathers, Jonathan, et al.
Publicado: (2015)

5613081 GAPS IN DATA ON GLOBAL PREVALENCE AND BIRTH PREVALENCE OF SICKLE CELL DISEASE AND SICKLE CELL TRAIT: CALL FOR ACTION TO SCALE UP AND HARMONIZE DATA COLLECTION
por: Colombatti, R., et al.
Publicado: (2023)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

S128: CONTINUOUS QUALITY IMPROVEMENT IN PAEDIATRIC SICKLE CELL DISEASE
por: Ahemad, E, et al.
Publicado: (2022)

Mechanistic insights and characterization of cardiomyopathy due to Sickle Cell Disease
por: Patel, Amit R, et al.
Publicado: (2012)

O-10: SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND UNMET NEEDS AS REPORTED BY PATIENTS AND CAREGIVERS
por: I., ODAME, et al.
Publicado: (2022)

5612992 SICKLE CELL HEALTH AWARENESS, PERSPECTIVES, AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS AND CAREGIVERS IN THE UK
por: Inusa, B.P.D., et al.
Publicado: (2023)

The C5 region of HIV-1 gp120 binds specific
por: Dalgleish, A, et al.
Publicado: (2006)

5607610 HETEROGENEITY IN COGNITIVE PRESENTATIONS AMONG CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE
por: Hardy, S.J., et al.
Publicado: (2023)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
por: Brito, M., et al.
Publicado: (2023)

5610692 PAIN BURDEN PREDICTS EXECUTIVE FUNCTION IN PAEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Chen, Y., et al.
Publicado: (2023)

S127: CONSORTIUM ON NEWBORN SCREENING IN AFRICA FOR SICKLE CELL DISEASE
por: Nnodu, O, et al.
Publicado: (2022)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
por: Inusa, B, et al.
Publicado: (2022)

O-07: TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.
por: Lugthart, S, et al.
Publicado: (2022)

S125: THE ROLE OF THE MICROBIOME AS A SICKLE CELL DISEASE MODIFIER: AN EXPERT REVIEW
por: Oosterwyk, C, et al.
Publicado: (2022)

5613275 USE OF CONSUMER WEARABLES TO PREDICT PAIN IN PATIENTS WITH SICKLE CELL DISEASE
por: Vuong, C., et al.
Publicado: (2023)

Care of the Critically Ill Pediatric Sickle Cell Patient
por: Rosanwo, Tolulope, et al.
Publicado: (2018)

7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
por: Giannini, EH, et al.
Publicado: (2008)

O-11: AUTOMATED QUANTIFICATION OF POCKED RED BLOOD CELLS CORRELATES WITH SPLEEN SIZE IN SICKLE CELL DISEASE
por: A., SISSOKO, et al.
Publicado: (2022)

Neurodevelopmental outcomes are normal in congenital hypothyroid children diagnosed early and treated aggressively over the first three years
por: Albert, Ben, et al.
Publicado: (2013)

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
por: Andemariam, B., et al.
Publicado: (2023)

5612627 MORTALITY, CHRONIC MORBIDITY AND INTENSITY OF TREATMENTS IN A NATURAL HISTORY COHORT OF SICKLE CELL DISEASE
por: Reggiani, G., et al.
Publicado: (2023)

Myocardial extracellular volume expansion in patients with hypertension
por: Neilan, Tomas G, et al.
Publicado: (2013)

Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination
por: Pothast, Cilia R., et al.
Publicado: (2022)

S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA
por: Ohene-Frempong, K, et al.
Publicado: (2022)

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE
por: de la Fuente, J., et al.
Publicado: (2023)

Sickle cell detection using a smartphone
por: Knowlton, S. M., et al.
Publicado: (2015)

MR-Augmented Cardiopulmonary Exercise Testing- a proof of concept in Sickle Cell Disease (SCD)
por: Ako, Emmanuel O, et al.
Publicado: (2016)

S265: MATERNAL AND PERINATAL OUTCOMES OF SICKLE CELL DISEASE IN PREGNANCY: A NATIONWIDE STUDY IN FRANCE.
por: Corsia, Alice, et al.
Publicado: (2023)

S278: CEREBRAL HEMODYNAMICS AND OXYGEN METABOLISM IN PATIENTS WITH MILD AND SEVERE SICKLE CELL DISEASE AND THALASSEMIA
por: Afzali-Hashemi, Liza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sc7nbieeb2rcdts524gu3jktfm